Nesivine Baby Sine Conservans (Oxymetazoline Hydrochloride)

Oxymetazoline is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it binds to alpha‑1 receptors on blood‑vessel walls, causing vasoconstriction. This reduces swelling of the nasal lining, opens the airway, and improves breathing.

The exact dose is determined by the prescribing healthcare professional based on age, weight, and severity of symptoms. Users should follow the label instructions and the prescriber’s guidance without exceeding the recommended number of sprays per day.

Safety data for oxymetazoline in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using the product to weigh potential benefits against possible risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Oxymetazoline provides rapid, localized vasoconstriction and typically lasts longer than phenylephrine, another common OTC decongestant. Unlike systemic decongestants, it has minimal systemic absorption when used as directed, but prolonged use can cause rebound congestion, a risk shared with many topical agents.

Store the nasal spray at temperatures below 25 °C (77 °F). Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

The product is administered intranasally. The user gently inserts the spray tip into one nostril, inhales lightly, and presses the actuator to deliver the recommended number of sprays. The same procedure is repeated in the other nostril if required, following label directions.

Serious risks include rebound nasal congestion after prolonged use, elevated blood pressure, hypertension, and rare systemic effects such as cardiac arrhythmias. If any severe symptoms occur, discontinue use and seek medical attention promptly.

Individuals with known hypersensitivity to oxymetazoline or any formulation components should avoid the product. It is also contraindicated in patients with severe hypertension, coronary artery disease, or those taking monoamine oxidase inhibitors without medical supervision.